Skip to main content
Top
Gepubliceerd in: Quality of Life Research 12/2020

11-08-2020

Psychometric properties comparison between EQ-5D-5L and EQ-5D-3L in the general Thai population

Auteurs: Krittaphas Kangwanrattanakul, Porntip Parmontree

Gepubliceerd in: Quality of Life Research | Uitgave 12/2020

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Purpose

Evidence for the EQ-5D-5L’s psychometric properties in the general Thai population is limited. This study aimed to compare ceiling effect, discriminatory power, response redistribution, validity, reliability between the EQ-5D-5L (5L) and the EQ-5D-3L (3L) in the general Thai population.

Methods

1200 participants were randomly selected. The Shannon index (\({H}^{{\prime}})\) and Shannon evenness index (\({J}^{{\prime}})\) determining discriminatory power of both EQ-5D versions in each dimension were compared. Test–retest reliability was evaluated using weighted kappa (k) and intraclass correlation coefficients (ICCs). Validity was evaluated by correlations between similar dimensions of the EQ-5D, WHOQOL-BREF, and SF-12v2 and known-groups validity. The ceiling effects for the 3L and for the 5L were compared.

Results

The 5L had lower ceiling effects than the 3L (49.08% vs 57.17%, p < 0.01). \({H}^{{\prime}}\) was higher for the 5L than for the 3L, but \({J}^{{\prime}}\) showed otherwise. Moderate correlations were detected between similar dimensions of the EQ-5D and the WHOQOL-BREF and SF-12v2. ICCs and k of the 3L were slightly higher than those of the 5L (ICCs: 0.78 vs 0.71) and (k: 0.42–0.63 vs 0.48–0.61), respectively. Older, female participants and those with comorbidities reported a lower utility index for both versions.

Conclusion

Evidence supported use of both EQ-5D versions in the general Thai population. The 5L had better ceiling effects and discriminant activity, while it showed comparable known-groups validity with the 3L. Nevertheless, evidence is limited for the superiority of reliability between these two versions, so more future research is required to investigate it.
Literatuur
1.
go back to reference Herdman, M., Gudex, C., Lloyd, A., Janssen, M. F., Kind, P., Parkin, D., et al. (2011). Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Quality of Life Research, 20(10), 1727–1736.PubMedPubMedCentralCrossRef Herdman, M., Gudex, C., Lloyd, A., Janssen, M. F., Kind, P., Parkin, D., et al. (2011). Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Quality of Life Research, 20(10), 1727–1736.PubMedPubMedCentralCrossRef
2.
go back to reference Oemar, M., & Janssen, B. (2013). EQ-5D-5L user guide-basic information on how to use the EQ-5D-5L instrument (p. 28). Rotterdam: EuroQol Group. Oemar, M., & Janssen, B. (2013). EQ-5D-5L user guide-basic information on how to use the EQ-5D-5L instrument (p. 28). Rotterdam: EuroQol Group.
4.
go back to reference EuroQoL Group. (1990). EuroQol—A new facility for the measurement of health-related quality of life. Health Policy, 16(3), 199–208.CrossRef EuroQoL Group. (1990). EuroQol—A new facility for the measurement of health-related quality of life. Health Policy, 16(3), 199–208.CrossRef
5.
go back to reference Rabin, R., & De Charro, F. (2001). EQ-5D: A measure of health status from the EuroQol Group. Annals of Medicine, 33(5), 337–343.PubMedCrossRef Rabin, R., & De Charro, F. (2001). EQ-5D: A measure of health status from the EuroQol Group. Annals of Medicine, 33(5), 337–343.PubMedCrossRef
6.
go back to reference Janssen, M. F., Pickard, A. S., Golicki, D., Gudex, C., Niewada, M., Scalone, L., et al. (2013). Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study. Quality of Life Research, 22(7), 1717–1727.PubMedCrossRef Janssen, M. F., Pickard, A. S., Golicki, D., Gudex, C., Niewada, M., Scalone, L., et al. (2013). Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study. Quality of Life Research, 22(7), 1717–1727.PubMedCrossRef
7.
go back to reference Kim, T. H., Jo, M. W., Lee, S. I., Kim, S. H., & Chung, S. M. (2013). Psychometric properties of the EQ-5D-5L in the general population of South Korea. Quality of Life Research, 22(8), 2245–2253.PubMedCrossRef Kim, T. H., Jo, M. W., Lee, S. I., Kim, S. H., & Chung, S. M. (2013). Psychometric properties of the EQ-5D-5L in the general population of South Korea. Quality of Life Research, 22(8), 2245–2253.PubMedCrossRef
8.
go back to reference Konig, H. H., Bernert, S., Angermeyer, M. C., Matschinger, H., Martinez, M., Vilagut, G., et al. (2009). Comparison of population health status in six European countries: results of a representative survey using the EQ-5D questionnaire. Medical Care, 47(2), 255–261.PubMedCrossRef Konig, H. H., Bernert, S., Angermeyer, M. C., Matschinger, H., Martinez, M., Vilagut, G., et al. (2009). Comparison of population health status in six European countries: results of a representative survey using the EQ-5D questionnaire. Medical Care, 47(2), 255–261.PubMedCrossRef
9.
go back to reference Rawlins, M. D., & Culyer, A. J. (2004). National Institute for Clinical Excellence and its value judgments. British Medical Journal, 329(7459), 224–227.PubMedCrossRefPubMedCentral Rawlins, M. D., & Culyer, A. J. (2004). National Institute for Clinical Excellence and its value judgments. British Medical Journal, 329(7459), 224–227.PubMedCrossRefPubMedCentral
10.
go back to reference Weinstein, M. C., Siegel, J. E., Gold, M. R., Kamlet, M. S., & Russell, L. B. (1996). Recommendations of the panel on cost-effectiveness in health and medicine. JAMA, 276(15), 1253–1258.PubMedCrossRef Weinstein, M. C., Siegel, J. E., Gold, M. R., Kamlet, M. S., & Russell, L. B. (1996). Recommendations of the panel on cost-effectiveness in health and medicine. JAMA, 276(15), 1253–1258.PubMedCrossRef
11.
go back to reference Sakthong, P. (2008). Measurement of clinical-effect: Utility. Journal of the Medical Association of Thailand, 91(Suppl 2), S43–52.PubMed Sakthong, P. (2008). Measurement of clinical-effect: Utility. Journal of the Medical Association of Thailand, 91(Suppl 2), S43–52.PubMed
12.
go back to reference Johnson, J. A., & Coons, S. J. (1998). Comparison of the EQ-5D and SF-12 in an adult US sample. Quality of Life Research, 7(2), 155–166.PubMedCrossRef Johnson, J. A., & Coons, S. J. (1998). Comparison of the EQ-5D and SF-12 in an adult US sample. Quality of Life Research, 7(2), 155–166.PubMedCrossRef
13.
go back to reference Petrou, S., & Hockley, C. (2005). An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population. Health Economics, 14(11), 1169–1189.PubMedCrossRef Petrou, S., & Hockley, C. (2005). An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population. Health Economics, 14(11), 1169–1189.PubMedCrossRef
14.
go back to reference McCrone, P., Patel, A., Knapp, M., Schene, A., Koeter, M., Amaddeo, F., et al. (2009). A comparison of SF-6D and EQ-5D utility scores in a study of patients with schizophrenia. The Journal of Mental Health Policy and Economics, 12(1), 27–31.PubMed McCrone, P., Patel, A., Knapp, M., Schene, A., Koeter, M., Amaddeo, F., et al. (2009). A comparison of SF-6D and EQ-5D utility scores in a study of patients with schizophrenia. The Journal of Mental Health Policy and Economics, 12(1), 27–31.PubMed
15.
go back to reference Petrou, S., Morrell, J., & Spiby, H. (2009). Assessing the empirical validity of alternative multi-attribute utility measures in the maternity context. Health Qual Life Outcomes, 7, 40.PubMedPubMedCentralCrossRef Petrou, S., Morrell, J., & Spiby, H. (2009). Assessing the empirical validity of alternative multi-attribute utility measures in the maternity context. Health Qual Life Outcomes, 7, 40.PubMedPubMedCentralCrossRef
16.
go back to reference Kularatna, S., Senanayake, S., Gunawardena, N., & Graves, N. (2019). Comparison of the EQ-5D-3L and the SF-6D (SF-36) contemporaneous utility scores in patients with chronic kidney disease in Sri Lanka: a cross-sectional survey. British Medical Journal Open, 9(2), e024854. Kularatna, S., Senanayake, S., Gunawardena, N., & Graves, N. (2019). Comparison of the EQ-5D-3L and the SF-6D (SF-36) contemporaneous utility scores in patients with chronic kidney disease in Sri Lanka: a cross-sectional survey. British Medical Journal Open, 9(2), e024854.
17.
go back to reference Pickard, A. S., De Leon, M. C., Kohlmann, T., Cella, D., & Rosenbloom, S. (2007). Psychometric comparison of the standard EQ-5D to a 5 level version in cancer patients. Medical Care, 45(3), 259–263.PubMedCrossRef Pickard, A. S., De Leon, M. C., Kohlmann, T., Cella, D., & Rosenbloom, S. (2007). Psychometric comparison of the standard EQ-5D to a 5 level version in cancer patients. Medical Care, 45(3), 259–263.PubMedCrossRef
18.
go back to reference Scalone, L., Ciampichini, R., Fagiuoli, S., Gardini, I., Fusco, F., Gaeta, L., et al. (2013). Comparing the performance of the standard EQ-5D-3L with the new version EQ-5D-5L in patients with chronic hepatic diseases. Quality of Life Research, 22(7), 1707–1716.PubMedCrossRef Scalone, L., Ciampichini, R., Fagiuoli, S., Gardini, I., Fusco, F., Gaeta, L., et al. (2013). Comparing the performance of the standard EQ-5D-3L with the new version EQ-5D-5L in patients with chronic hepatic diseases. Quality of Life Research, 22(7), 1707–1716.PubMedCrossRef
19.
go back to reference Kim, S. H., Kim, H. J., Lee, S. I., & Jo, M. W. (2012). Comparing the psychometric properties of the EQ-5D-3L and EQ-5D-5L in cancer patients in Korea. Quality of Life Research, 21(6), 1065–1073.PubMedCrossRef Kim, S. H., Kim, H. J., Lee, S. I., & Jo, M. W. (2012). Comparing the psychometric properties of the EQ-5D-3L and EQ-5D-5L in cancer patients in Korea. Quality of Life Research, 21(6), 1065–1073.PubMedCrossRef
20.
go back to reference Craig, B. M., Pickard, A. S., & Lubetkin, E. I. (2014). Health problems are more common, but less severe when measured using newer EQ-5D versions. Journal of Clinical Epidemiology, 67(1), 93–99.PubMedCrossRef Craig, B. M., Pickard, A. S., & Lubetkin, E. I. (2014). Health problems are more common, but less severe when measured using newer EQ-5D versions. Journal of Clinical Epidemiology, 67(1), 93–99.PubMedCrossRef
21.
go back to reference Feng, Y., Devlin, N., & Herdman, M. (2015). Assessing the health of the general population in England: how do the three- and five-level versions of EQ-5D compare? Health Qual Life Outcomes, 13, 171.PubMedPubMedCentralCrossRef Feng, Y., Devlin, N., & Herdman, M. (2015). Assessing the health of the general population in England: how do the three- and five-level versions of EQ-5D compare? Health Qual Life Outcomes, 13, 171.PubMedPubMedCentralCrossRef
22.
go back to reference Pattanaphesaj, J., & Thavorncharoensap, M. (2015). Measurement properties of the EQ-5D-5L compared to EQ-5D-3L in the Thai diabetes patients. Health and Quality of Life Outcomes, 13, 14.PubMedPubMedCentralCrossRef Pattanaphesaj, J., & Thavorncharoensap, M. (2015). Measurement properties of the EQ-5D-5L compared to EQ-5D-3L in the Thai diabetes patients. Health and Quality of Life Outcomes, 13, 14.PubMedPubMedCentralCrossRef
23.
go back to reference Sakthong, P., Sonsa-Ardjit, N., Sukarnjanaset, P., & Munpan, W. (2015). Psychometric properties of the EQ-5D-5L in Thai patients with chronic diseases. Quality of Life Research, 24(12), 3015–3022.PubMedCrossRef Sakthong, P., Sonsa-Ardjit, N., Sukarnjanaset, P., & Munpan, W. (2015). Psychometric properties of the EQ-5D-5L in Thai patients with chronic diseases. Quality of Life Research, 24(12), 3015–3022.PubMedCrossRef
24.
go back to reference Pattanaphesaj, J., Thavorncharoensap, M., Ramos-Goni, J. M., Tongsiri, S., Ingsrisawang, L., & Teerawattananon, Y. (2018). The EQ-5D-5L valuation study in Thailand. Expert Review of Pharmacoeconomics & Outcomes Research, 18(5), 551–558.CrossRef Pattanaphesaj, J., Thavorncharoensap, M., Ramos-Goni, J. M., Tongsiri, S., Ingsrisawang, L., & Teerawattananon, Y. (2018). The EQ-5D-5L valuation study in Thailand. Expert Review of Pharmacoeconomics & Outcomes Research, 18(5), 551–558.CrossRef
25.
go back to reference Tongsiri, S., & Cairns, J. (2011). Estimating population-based values for EQ-5D health states in Thailand. Value Health, 14(8), 1142–1145.PubMedCrossRef Tongsiri, S., & Cairns, J. (2011). Estimating population-based values for EQ-5D health states in Thailand. Value Health, 14(8), 1142–1145.PubMedCrossRef
26.
go back to reference The World Health Orgaization Quality of Life Group. (1998). The World Health Organization quality of life assessment (WHOQOL): development and general psychometric properties. Social Science & Medicine, 46(12), 1569–1585.CrossRef The World Health Orgaization Quality of Life Group. (1998). The World Health Organization quality of life assessment (WHOQOL): development and general psychometric properties. Social Science & Medicine, 46(12), 1569–1585.CrossRef
27.
go back to reference Mahatnirundkul, S. (1998). Comparison of the WHOQOL-100 and the WHOQOL-BREF (26 items). Journal of Mental Health of Thailand, 5, 4–15. Mahatnirundkul, S. (1998). Comparison of the WHOQOL-100 and the WHOQOL-BREF (26 items). Journal of Mental Health of Thailand, 5, 4–15.
28.
go back to reference Ware, J. E., Jr., Kosinski, M., & Keller, S. D. (2002). SF-12: how to score the SF-12 physical and mental health summary scales. Boston: Health Assessment Lab, QualityMetric Inc. Ware, J. E., Jr., Kosinski, M., & Keller, S. D. (2002). SF-12: how to score the SF-12 physical and mental health summary scales. Boston: Health Assessment Lab, QualityMetric Inc.
29.
go back to reference Chariyalertsak, S., Wansom, T., Kawichai, S., Ruangyuttikarna, C., Kemerer, V., & Wu, A. (2011). Reliability and validity of Thai versions of the MOS-HIV and SF12 quality of life questionnaires in people living with HIV/AIDS. Health and Quality of Life Outcomes, 9, 1–9.CrossRef Chariyalertsak, S., Wansom, T., Kawichai, S., Ruangyuttikarna, C., Kemerer, V., & Wu, A. (2011). Reliability and validity of Thai versions of the MOS-HIV and SF12 quality of life questionnaires in people living with HIV/AIDS. Health and Quality of Life Outcomes, 9, 1–9.CrossRef
30.
go back to reference Phantipa, S., Vijj, K., & Win, W.-W. (2017). Assessment of health-related quality of life in Thai patients after heart surgery. Asian Biomedicine, 9(2), 203–210. Phantipa, S., Vijj, K., & Win, W.-W. (2017). Assessment of health-related quality of life in Thai patients after heart surgery. Asian Biomedicine, 9(2), 203–210.
31.
go back to reference Ware, J., Kosinski, M., Turner-Bowker, D., & Gandek, B. (2002). How to score SF-12 items SF-12 v2 How to Score Version 2 of the SF-12 Health Survey, 29–38. Ware, J., Kosinski, M., Turner-Bowker, D., & Gandek, B. (2002). How to score SF-12 items SF-12 v2 How to Score Version 2 of the SF-12 Health Survey, 29–38.
32.
go back to reference Terwee, C. B., Bot, S. D., de Boer, M. R., van der Windt, D. A., Knol, D. L., Dekker, J., et al. (2007). Quality criteria were proposed for measurement properties of health status questionnaires. Journal of Clinical Epidemiology, 60(1), 34–42.PubMedCrossRef Terwee, C. B., Bot, S. D., de Boer, M. R., van der Windt, D. A., Knol, D. L., Dekker, J., et al. (2007). Quality criteria were proposed for measurement properties of health status questionnaires. Journal of Clinical Epidemiology, 60(1), 34–42.PubMedCrossRef
33.
go back to reference Kang, E. J., & Ko, S. K. (2009). A catalogue of EQ-5D utility weights for chronic diseases among noninstitutionalized community residents in Korea. Value Health, 12(Suppl 3), S114–117.PubMedCrossRef Kang, E. J., & Ko, S. K. (2009). A catalogue of EQ-5D utility weights for chronic diseases among noninstitutionalized community residents in Korea. Value Health, 12(Suppl 3), S114–117.PubMedCrossRef
34.
go back to reference Janssen, M. F., Birnie, E., Haagsma, J. A., & Bonsel, G. J. (2008). Comparing the standard EQ-5D three-level system with a five-level version. Value in Health, 11(2), 275–284.PubMedCrossRef Janssen, M. F., Birnie, E., Haagsma, J. A., & Bonsel, G. J. (2008). Comparing the standard EQ-5D three-level system with a five-level version. Value in Health, 11(2), 275–284.PubMedCrossRef
35.
go back to reference Cohen, P. (1974). Regression and correlation. In Statistic in medicine. Boston: Litttle Brown and Company. Cohen, P. (1974). Regression and correlation. In Statistic in medicine. Boston: Litttle Brown and Company.
36.
go back to reference Fleiss, J. L., Levin, B., & Paik, M. C. (1981). The measurement of interrater agreement. Statistical Methods for Rates and Proportions, 2(212–236), 22–23. Fleiss, J. L., Levin, B., & Paik, M. C. (1981). The measurement of interrater agreement. Statistical Methods for Rates and Proportions, 2(212–236), 22–23.
37.
go back to reference Golicki, D., Niewada, M., Karlinska, A., Buczek, J., Kobayashi, A., Janssen, M. F., et al. (2015). Comparing responsiveness of the EQ-5D-5L, EQ-5D-3L and EQ-VAS in stroke patients. Quality of Life Research, 24(6), 1555–1563.PubMedCrossRef Golicki, D., Niewada, M., Karlinska, A., Buczek, J., Kobayashi, A., Janssen, M. F., et al. (2015). Comparing responsiveness of the EQ-5D-5L, EQ-5D-3L and EQ-VAS in stroke patients. Quality of Life Research, 24(6), 1555–1563.PubMedCrossRef
38.
go back to reference Jia, Y. X., Cui, F. Q., Li, L., Zhang, D. L., Zhang, G. M., Wang, F. Z., et al. (2014). Comparison between the EQ-5D-5L and the EQ-5D-3L in patients with hepatitis B. Quality of Life Research, 23(8), 2355–2363.PubMedCrossRef Jia, Y. X., Cui, F. Q., Li, L., Zhang, D. L., Zhang, G. M., Wang, F. Z., et al. (2014). Comparison between the EQ-5D-5L and the EQ-5D-3L in patients with hepatitis B. Quality of Life Research, 23(8), 2355–2363.PubMedCrossRef
39.
go back to reference Poor, A. K., Rencz, F., Brodszky, V., Gulacsi, L., Beretzky, Z., Hidvegi, B., et al. (2017). Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L in psoriasis patients. Quality of Life Research, 26(12), 3409–3419.PubMedCrossRef Poor, A. K., Rencz, F., Brodszky, V., Gulacsi, L., Beretzky, Z., Hidvegi, B., et al. (2017). Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L in psoriasis patients. Quality of Life Research, 26(12), 3409–3419.PubMedCrossRef
40.
go back to reference Ferreira, L. N., Ferreira, P. L., Ribeiro, F. P., & Pereira, L. N. (2016). Comparing the performance of the EQ-5D-3L and the EQ-5D-5L in young Portuguese adults. Health and Quality of Life Outcomes, 14, 89.PubMedPubMedCentralCrossRef Ferreira, L. N., Ferreira, P. L., Ribeiro, F. P., & Pereira, L. N. (2016). Comparing the performance of the EQ-5D-3L and the EQ-5D-5L in young Portuguese adults. Health and Quality of Life Outcomes, 14, 89.PubMedPubMedCentralCrossRef
41.
go back to reference Buchholz, I., Janssen, M. F., Kohlmann, T., & Feng, Y. S. (2018). A systematic review of studies comparing the measurement properties of the three-level and five-level versions of the EQ-5D. Pharmacoeconomics, 36(6), 645–661.PubMedPubMedCentralCrossRef Buchholz, I., Janssen, M. F., Kohlmann, T., & Feng, Y. S. (2018). A systematic review of studies comparing the measurement properties of the three-level and five-level versions of the EQ-5D. Pharmacoeconomics, 36(6), 645–661.PubMedPubMedCentralCrossRef
42.
go back to reference Yfantopoulos, J., Chantzaras, A., & Kontodimas, S. (2017). Assessment of the psychometric properties of the EQ-5D-3L and EQ-5D-5L instruments in psoriasis. Archives of Dermatological Research, 309(5), 357–370.PubMedCrossRef Yfantopoulos, J., Chantzaras, A., & Kontodimas, S. (2017). Assessment of the psychometric properties of the EQ-5D-3L and EQ-5D-5L instruments in psoriasis. Archives of Dermatological Research, 309(5), 357–370.PubMedCrossRef
43.
go back to reference Pan, C. W., Sun, H. P., Wang, X., Ma, Q., Xu, Y., Luo, N., et al. (2015). The EQ-5D-5L index score is more discriminative than the EQ-5D-3L index score in diabetes patients. Quality of Life Research, 24(7), 1767–1774.PubMedCrossRef Pan, C. W., Sun, H. P., Wang, X., Ma, Q., Xu, Y., Luo, N., et al. (2015). The EQ-5D-5L index score is more discriminative than the EQ-5D-3L index score in diabetes patients. Quality of Life Research, 24(7), 1767–1774.PubMedCrossRef
44.
go back to reference Greene, M. E., Rader, K. A., Garellick, G., Malchau, H., Freiberg, A. A., & Rolfson, O. (2015). The EQ-5D-5L improves on the EQ-5D-3L for health-related quality-of-life assessment in patients undergoing total hip arthroplasty. Clinical Orthopaedics and Related Research, 473(11), 3383–3390.PubMedCrossRef Greene, M. E., Rader, K. A., Garellick, G., Malchau, H., Freiberg, A. A., & Rolfson, O. (2015). The EQ-5D-5L improves on the EQ-5D-3L for health-related quality-of-life assessment in patients undergoing total hip arthroplasty. Clinical Orthopaedics and Related Research, 473(11), 3383–3390.PubMedCrossRef
45.
go back to reference Buchholz, I., Thielker, K., Feng, Y. S., Kupatz, P., & Kohlmann, T. (2015). Measuring changes in health over time using the EQ-5D-3L and 5L: A head-to-head comparison of measurement properties and sensitivity to change in a German inpatient rehabilitation sample. Quality of Life Research, 24(4), 829–835.PubMedCrossRef Buchholz, I., Thielker, K., Feng, Y. S., Kupatz, P., & Kohlmann, T. (2015). Measuring changes in health over time using the EQ-5D-3L and 5L: A head-to-head comparison of measurement properties and sensitivity to change in a German inpatient rehabilitation sample. Quality of Life Research, 24(4), 829–835.PubMedCrossRef
46.
go back to reference Martí-Pastor, M., Pont, A., Ávila, M., Garin, O., Vilagut, G., Forero, C. G., et al. (2018). Head-to-head comparison between the EQ-5D-5L and the EQ-5D-3L in general population health surveys. Population Health Metrics, 16(1), 14.PubMedPubMedCentralCrossRef Martí-Pastor, M., Pont, A., Ávila, M., Garin, O., Vilagut, G., Forero, C. G., et al. (2018). Head-to-head comparison between the EQ-5D-5L and the EQ-5D-3L in general population health surveys. Population Health Metrics, 16(1), 14.PubMedPubMedCentralCrossRef
47.
go back to reference Conner-Spady, B. L., Marshall, D. A., Bohm, E., Dunbar, M. J., Loucks, L., Al Khudairy, A., et al. (2015). Reliability and validity of the EQ-5D-5L compared to the EQ-5D-3L in patients with osteoarthritis referred for hip and knee replacement. Quality of Life Research, 24(7), 1775–1784.PubMedCrossRef Conner-Spady, B. L., Marshall, D. A., Bohm, E., Dunbar, M. J., Loucks, L., Al Khudairy, A., et al. (2015). Reliability and validity of the EQ-5D-5L compared to the EQ-5D-3L in patients with osteoarthritis referred for hip and knee replacement. Quality of Life Research, 24(7), 1775–1784.PubMedCrossRef
48.
go back to reference Yfantopoulos, J. N., & Chantzaras, A. E. (2017). Validation and comparison of the psychometric properties of the EQ-5D-3L and EQ-5D-5L instruments in Greece. The European Journal of Health Economics, 18(4), 519–531.PubMedCrossRef Yfantopoulos, J. N., & Chantzaras, A. E. (2017). Validation and comparison of the psychometric properties of the EQ-5D-3L and EQ-5D-5L instruments in Greece. The European Journal of Health Economics, 18(4), 519–531.PubMedCrossRef
49.
go back to reference Kangwanrattanakul, K., Gross, C. R., Sunantiwat, M., & Thavorncharoensap, M. (2019). Adding two culture-specific 'bolt-on' dimensions on the Thai version of EQ-5D-5L: an exploratory study in patients with diabetes. Expert Rev Pharmacoecon Outcomes Res, 19(3), 321–329.PubMedCrossRef Kangwanrattanakul, K., Gross, C. R., Sunantiwat, M., & Thavorncharoensap, M. (2019). Adding two culture-specific 'bolt-on' dimensions on the Thai version of EQ-5D-5L: an exploratory study in patients with diabetes. Expert Rev Pharmacoecon Outcomes Res, 19(3), 321–329.PubMedCrossRef
50.
go back to reference Kangwanrattanakul, K., & Auamnoy, T. (2019). Psychometric testing of the health-related quality of life measurement, SF-36v2, in the general population of Thailand. Expert Review of Pharmacoeconomics & Outcomes Research, 19(3), 313–320.CrossRef Kangwanrattanakul, K., & Auamnoy, T. (2019). Psychometric testing of the health-related quality of life measurement, SF-36v2, in the general population of Thailand. Expert Review of Pharmacoeconomics & Outcomes Research, 19(3), 313–320.CrossRef
51.
go back to reference Streiner, D. L., Norman, G. R., & Cairney, J. (2015). Health measurement scales: a practical guide to their development and use. New York: Oxford University Press.CrossRef Streiner, D. L., Norman, G. R., & Cairney, J. (2015). Health measurement scales: a practical guide to their development and use. New York: Oxford University Press.CrossRef
52.
go back to reference Marx, R. G., Menezes, A., Horovitz, L., Jones, E. C., & Warren, R. F. (2003). A comparison of two time intervals for test-retest reliability of health status instruments. Journal of Clinical Epidemiology, 56(8), 730–735.PubMedCrossRef Marx, R. G., Menezes, A., Horovitz, L., Jones, E. C., & Warren, R. F. (2003). A comparison of two time intervals for test-retest reliability of health status instruments. Journal of Clinical Epidemiology, 56(8), 730–735.PubMedCrossRef
Metagegevens
Titel
Psychometric properties comparison between EQ-5D-5L and EQ-5D-3L in the general Thai population
Auteurs
Krittaphas Kangwanrattanakul
Porntip Parmontree
Publicatiedatum
11-08-2020
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 12/2020
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-020-02595-2

Andere artikelen Uitgave 12/2020

Quality of Life Research 12/2020 Naar de uitgave